Genetron Holdings - Stock Price History | GTH

Historical daily share price chart and data for Genetron Holdings since 2021 adjusted for splits. The latest closing stock price for Genetron Holdings as of September 24, 2021 is 13.90.
  • The all-time high Genetron Holdings stock closing price was 30.64 on February 12, 2021.
  • The Genetron Holdings 52-week high stock price is 31.54, which is 126.9% above the current share price.
  • The Genetron Holdings 52-week low stock price is 9.20, which is 33.8% below the current share price.
  • The average Genetron Holdings stock price for the last 52 weeks is 17.63.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Genetron Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 12.5178 16.0000 16.0000 9.1000 14.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.250B $0.065B
Genetron Holdings Limited provides precision oncology platform principally in China. It specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company's product and service portfolio cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. Genetron Holdings Limited is based in BEIJING, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71